1
|
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.
|
Nat Med
|
1998
|
6.36
|
2
|
Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles.
|
J Immunol
|
2001
|
6.32
|
3
|
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.
|
Nat Med
|
2001
|
5.71
|
4
|
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.
|
J Exp Med
|
1999
|
5.55
|
5
|
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.
|
J Cell Biol
|
1999
|
4.87
|
6
|
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
|
Nat Cell Biol
|
1999
|
4.53
|
7
|
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.
|
Immunity
|
2002
|
2.31
|
8
|
TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
|
J Immunol
|
1999
|
2.05
|
9
|
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.
|
Proc Natl Acad Sci U S A
|
1998
|
1.74
|
10
|
The cell biology of antigen presentation in dendritic cells.
|
Curr Opin Immunol
|
2001
|
1.63
|
11
|
Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome.
|
J Cell Biol
|
1998
|
1.60
|
12
|
The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.
|
J Exp Med
|
1994
|
1.59
|
13
|
Tumor-derived exosomes: a new source of tumor rejection antigens.
|
Vaccine
|
2002
|
1.33
|
14
|
Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes.
|
J Cell Biol
|
1997
|
1.30
|
15
|
Structural bases of Fc gamma receptor functions.
|
Immunol Rev
|
1992
|
1.23
|
16
|
Role of associated gamma-chain in tyrosine kinase activation via murine Fc gamma RIII.
|
EMBO J
|
1992
|
1.20
|
17
|
syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes.
|
EMBO J
|
1998
|
1.19
|
18
|
Vimentin filaments in fibroblasts are a reservoir for SNAP23, a component of the membrane fusion machinery.
|
Mol Biol Cell
|
2000
|
1.15
|
19
|
A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
|
EMBO J
|
1998
|
1.13
|
20
|
HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments.
|
Immunity
|
1996
|
1.09
|
21
|
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
|
J Immunol
|
2000
|
1.07
|
22
|
Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model.
|
Am J Transplant
|
2006
|
1.07
|
23
|
Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.
|
Clin Cancer Res
|
2000
|
1.00
|
24
|
Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes.
|
J Cell Biol
|
1993
|
0.98
|
25
|
Antigen traffic pathways in dendritic cells.
|
Traffic
|
2000
|
0.96
|
26
|
Dendritic cells or their exosomes are effective biotherapies of cancer.
|
Eur J Cancer
|
1999
|
0.94
|
27
|
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.
|
Oncogene
|
2010
|
0.92
|
28
|
Phagocytosis and antigen presentation.
|
Semin Immunol
|
2001
|
0.91
|
29
|
The isotypic circuit: immunoglobulins, Fc receptors and immunoglobulin binding factors.
|
Int Rev Immunol
|
1987
|
0.89
|
30
|
Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell lines.
|
Mol Immunol
|
1988
|
0.89
|
31
|
Lonely MHC molecules seeking immunogenic peptides for meaningful relationships.
|
Curr Opin Cell Biol
|
1995
|
0.88
|
32
|
Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
|
Mol Biol Cell
|
1999
|
0.85
|
33
|
Exosomes in cancer immunotherapy: preclinical data.
|
Adv Exp Med Biol
|
2001
|
0.84
|
34
|
MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
|
J Immunol
|
1998
|
0.83
|
35
|
Methylation in the 5' region of the murine beta Fc gamma R gene regulates the expression of Fc gamma receptor II.
|
J Immunol
|
1988
|
0.82
|
36
|
Murine low-affinity receptors for the Fc portion of IgG. Roles in cell activation and ligand internalization.
|
Receptors Channels
|
1993
|
0.82
|
37
|
Unmethylation of specific sites in the 5' region is critical for the expression of murine alpha Fc gamma R gene.
|
J Immunol
|
1990
|
0.79
|
38
|
Software for the quantitative evaluation of in vitro monoclonal antibody production from ELISA data.
|
J Immunol Methods
|
1987
|
0.78
|
39
|
Bases for an isotypic network.
|
Mol Immunol
|
1986
|
0.78
|
40
|
Intracellular signaling and endosomal trafficking of immunoreceptors. Shared effectors underlying MHC class II-restricted antigen presentation.
|
Immunol Lett
|
1997
|
0.78
|
41
|
Molecular heterogeneity of murine IgG-BF.
|
Mol Immunol
|
1986
|
0.77
|
42
|
Immunoglobulin G-binding factors (IgG-BF) inhibit IgG secretion by, as well as proliferation of, hybridoma B cells.
|
Immunol Lett
|
1987
|
0.77
|
43
|
Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.
|
Immunol Res
|
1992
|
0.77
|
44
|
Deficient antigen processing of a protein quaternary structure can be overcome by receptor-mediated uptake.
|
Eur J Immunol
|
1993
|
0.75
|
45
|
In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.
|
Immunol Res
|
1992
|
0.75
|
46
|
A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cells.
|
J Immunol Methods
|
1987
|
0.75
|
47
|
Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor.
|
Cancer Detect Prev
|
1988
|
0.75
|
48
|
21.1.1, a novel activation marker of T and B cells.
|
Mol Immunol
|
1991
|
0.75
|
49
|
Control of B cell function by Fc gamma receptor-positive T cells and immunoglobulin-binding factors.
|
Contrib Microbiol Immunol
|
1989
|
0.75
|